Advertisement

ADVERTISEMENT

drug-eluting balloons

Letter to the Editor
Erectile Dysfunction Treatment With Sirolimus-Eluting Balloons Due to Bilateral Internal Pudendal Arterial Stenosis
01/13/2021

Alberto Cereda, MD1; Marco Toselli, MD1; Francesco Gallo, MD1; Alessandra Laricchia, MD1; Antonio Mangieri, MD1; Gabriele Tumminello, MD2; Francesco Giannini, MD1; Antonio Colombo, Prof1; Giuseppe Massimo Sangiorgi, Prof2,3

 

1Interventional Cardiology Unit, GVM Care & Research, Maria Cecilia Hospital, Cotignola, Italy; 2Division of Cardiology, ASST Santi Paolo e Carlo, Milan, Italy; 3Department of Biomedicine and Prevention, Cardiac Cath Lab, University of Rome Tor Vergata, Rome, Italy

Alberto Cereda, MD1; Marco Toselli, M...
A 52-year-old man with multiple cardiovascular risk factors, including arterial hypertension and diabetes mellitus type II, was referred to our interventional cardiology unit because of a poor response to year-long treatment.
A 52-year-old man with multiple cardiovascular risk factors, including arterial hypertension and diabetes mellitus type II, was referred to our interventional cardiology unit because of a poor response to year-long treatment.
A 52-year-old man with multiple...
01/13/2021
Vascular Disease Management
Original Contribution
Outcomes With Drug-Coated Balloons for Treating the Side Branch of Coronary Bifurcation Lesions
09/15/2018

Michael Megaly, MD, MS1,2;  Michael Rofael, MD3;  Marwan Saad, MD, MS4,5;  Mehdi Shishehbor, DO, MPH, PhD6; Emmanouil S. Brilakis, MD, PhD1

 

Michael Megaly, MD, MS1,2;  Michael R...
We performed a systematic review of all studies published between January 2000 and February 2018 reporting the outcomes of DCB vs non-coated balloon angioplasty (BA) in the treatment of the SB in coronary bifurcation lesions. Outcomes...
We performed a systematic review of all studies published between January 2000 and February 2018 reporting the outcomes of DCB vs non-coated balloon angioplasty (BA) in the treatment of the SB in coronary bifurcation lesions. Outcomes...
We performed a systematic review...
09/15/2018
Journal of Invasive Cardiology
Editor's Corner
The DRASTICO Trial: DEB vs DES for Complex Peripheral Intervention
02/08/2017
There is great debate about whether drug-eluting stent or drug-eluting balloon therapy should be utilized to treat symptomatic peripheral arterial disease.
There is great debate about whether drug-eluting stent or drug-eluting balloon therapy should be utilized to treat symptomatic peripheral arterial disease.
There is great debate about...
02/08/2017
Vascular Disease Management
Editor's Corner
We Need to Compare Devices for Lower-Limb Revascularization
08/30/2016

Lawrence A. Garcia, MD

 

St. Elizabeth’s Medical Center, Brighton, Massachusetts

Lawrence A. Garcia, MD   St. Elizab...
Fortunately, there has been a large increase in the scientific data to support many, if not all, of the devices approved by the US Food and Drug Administration (FDA) and currently in use for lower-extremity revascularization in both the...
Fortunately, there has been a large increase in the scientific data to support many, if not all, of the devices approved by the US Food and Drug Administration (FDA) and currently in use for lower-extremity revascularization in both the...
Fortunately, there has been a...
08/30/2016
Vascular Disease Management
Editor's Corner
Pitfalls and New Options for Treatment of Femoral and Popliteal In-Stent Restenosis
08/30/2016
In-stent restenosis is a growing clinical challenge, and repeat interventions are costly and carry risks. There are new devices available that could, in combination with other therapies, reduce cost and improve results for in-stent restenosis...
In-stent restenosis is a growing clinical challenge, and repeat interventions are costly and carry risks. There are new devices available that could, in combination with other therapies, reduce cost and improve results for in-stent restenosis...
In-stent restenosis is a growing...
08/30/2016
Vascular Disease Management
Standardization of Care for Complex Peripheral Arterial Disease
05/22/2016
A standard does not yet exist for complex disease in the peripheral arteries. Interventionalists rely on small sets of data and personal experience to provide care, and the solution for this problem is still unclear.
A standard does not yet exist for complex disease in the peripheral arteries. Interventionalists rely on small sets of data and personal experience to provide care, and the solution for this problem is still unclear.
A standard does not yet exist...
05/22/2016
Vascular Disease Management
Editor's Corner
Standardization of Care for Complex Peripheral Arterial Disease
05/22/2016
A standard does not yet exist for complex disease in the peripheral arteries. Interventionalists rely on small sets of data and personal experience to provide care, and the solution for this problem is still unclear.
A standard does not yet exist for complex disease in the peripheral arteries. Interventionalists rely on small sets of data and personal experience to provide care, and the solution for this problem is still unclear.
A standard does not yet exist...
05/22/2016
Vascular Disease Management
The Current State of Endovascular Intervention for Peripheral Arterial Disease
10/03/2015

Rigved V. Tadwalkar, MD, MS; Michael S. Lee, MD

 

UCLA Medical Center, Los Angeles, California

Rigved V. Tadwalkar, MD, MS; Michael ...
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of...
10/03/2015
Vascular Disease Management
The Current State of Endovascular Intervention for Peripheral Arterial Disease
10/03/2015
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of modalities for peripheral arterial disease complemented by refinements in technique for new devices foreshadows a bright future for new endovascular approaches in the treatment of PAD.
The continued study of...
10/03/2015
Vascular Disease Management
Interventional Treatment of Superficial Femoral Artery In-Stent Restenosis
07/01/2015
Treatment of in-stent restenosis with standard balloon angioplasty has been associated with poor patency and complications. New therapy options that add lasers and drug-eluting technologies could improve results.
Treatment of in-stent restenosis with standard balloon angioplasty has been associated with poor patency and complications. New therapy options that add lasers and drug-eluting technologies could improve results.
Treatment of in-stent restenosis...
07/01/2015
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use